Orthofix Medical Inc. (OFIX) stock
Close on Nov 11, 2026Market cap $292.46MP/E –Yield –
Orthofix Medical Inc. grew revenue 2.1% to $835.41M over the twelve months to Sep 30, 2026. Free cash flow was -$44.46M. At the latest close the market valued the company at $292.46M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $292.46M
- P/E ratio
- –
- Price to sales
- 0.35
- Price to book
- 0.68
- Dividend yield
- –
- Free cash flow yield
- -15.20%
Fundamentals
- Revenue
- $835.41M
- Net income
- -$45.00M
- EPS, diluted
- -$1.12
- Free cash flow
- -$44.46M
- Book value per share
- $10.43
- Diluted shares
- 41M
Trading
- Next earnings
- Feb 23, 2027 (estimated, before the open)
- Previous close
- $7.12
- Open
- $7.02
- Day's range
- $6.94 – $7.40
- Volume
- 763,517
- Average volume (20 days)
- 649,177
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 1.11
- 52-week range
- $6.52 – $16.42
- RSI (14 days)
- 31.2
- Volatility (1 year)
- 51.7%
- Relative volume
- 1.79×
- WACC
- 8.3%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | OFIX | S&P 500 | Difference | OFIX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -21.7% | -2.4% | −19.3 pts | ||
| 3 months | -30.4% | -1.2% | −29.3 pts | ||
| Year to date | -52.6% | +12.3% | −64.9 pts | ||
| 1 year | -53.3% | +12.4% | −65.8 pts | ||
| 3 years | -28.2% | +78.8% | −107.0 pts | -10.5% | +21.4% |
| 5 years | -78.0% | +75.2% | −153.2 pts | -26.1% | +11.9% |
| 10 years | -80.6% | +311.1% | −391.7 pts | -15.1% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Orthofix Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Orthofix Medical
Surgical & Medical Instruments & Apparatus
Orthofix Medical Inc. operates as a medical technology enterprise focused on spine care and limb reconstruction therapies. The company delivers an array of spinal and orthopedic solutions through key segments that include Global Spine and Global Limb Reconstruction. Its core product portfolio encompasses spinal implants, bone growth therapies, specialized biologics, enabling surgical technologies, and limb reconstruction devices designed to treat complex bone and musculoskeletal conditions. The company primarily serves surgeons, physicians, hospitals, and broader healthcare facilities, with its products and procedures utilized by patients requiring specialized orthopedic interventions.
Company profile, executives and historyOrthofix Medical stock: common questions
What is Orthofix Medical's stock price?
OFIX closed at $7.18 on Nov 11, 2026, up 0.84% on the day. Over the past 52 weeks it traded between $6.52 and $16.42.
What is Orthofix Medical's market cap?
Orthofix Medical was worth $292.46M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is OFIX's P/E ratio?
Orthofix Medical lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.12), so it has no meaningful P/E ratio.
How much revenue does Orthofix Medical make?
Orthofix Medical reported revenue of $835.41M for the twelve months to Sep 30, 2026, up 2.1% from a year earlier.
Does Orthofix Medical pay a dividend?
No. Orthofix Medical has not paid a cash dividend over the last twelve months.
When does Orthofix Medical report earnings next?
Orthofix Medical is expected to report Q4 FY2026 results on Feb 23, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has OFIX stock performed over the past year?
Including dividends, OFIX returned -53.3% over the past year, against +12.4% for the S&P 500.
How many OFIX shares are sold short?
2M shares were sold short at the latest FINRA report, 7.12% of the float, or 6.1 days of average trading volume.
Who are Orthofix Medical's competitors?
Companies most similar to Orthofix Medical by business, industry and size include ATEC, BVS, GMED, IART, AORT.
See a number that looks wrong?